cjc 1295 no dac / ipamorelin blend benefits CJC-1295 + CJC-1295 No DAC & Ipamorelin

Maintenance dose (week 5 onward): 1mg (1000mcg) tesamorelin + 200300mcg ipamorelin, adjusted based on IGF-1 response measured via serum blood work at week 6 and week 12

Why the Advanced Recomp Stack Adds CJC/Ipa to Retatrutide Foundation: Retatrutide Retatrutide alone produced the strongest weight-loss results documented in clinical trials: 24.2% mean body weight reduction at 48 weeks in Phase 2 [NEJM 2023] and 28.7% at 68 weeks in Phase 3 (TRIUMPH-4, December 2025)

Ipamorelin is described in the research literature as a selective agonist of the ghrelin receptor (also called the growth-hormone-secretagogue receptor)

Comprehensive Product Guide: Sermorelin & Ipamorelin Blend When evaluating growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormones (GHRHs) for laboratory research, the Sermorelin & Ipamorelin blend represents one of the most widely studied synergistic combinations

Cng thc cn c s kt hp hip ng vi Vitamin C ko di tc dng chng oxy ha